Delivery of inpatient cancer care varies greatly based on housing status
“Key takeaways: People with cancer experiencing homelessness appeared less likely to undergo surgery or receive systemic therapy. They also got discharged against medical advice more frequently.”
From Pathogen to Infectious Disease Diagnosis: Medical Tourism and an Outbreak of Fungal Meningitis
“Last year, Sarah Bergbower was a Doctorate of Clinical Laboratory Studies (DCLS) graduate student and rounding with the infectious disease service, when she was asked by her attending to participate in a case in what was becoming a major medical investigation.”
SGLT2i Outperforms DPP4i in Improving Hepatic Fibrosis Indices in MASLD
“Sodium-glucose co-transporter 2 inhibitors (SGLT2i) proved more effective than dipeptidyl peptidase 4 inhibitors (DPP4i) in ameliorating hepatic inflammation and fibrosis indices in patients with type 2 diabetes (T2D) and suspected metabolic dysfunction-associated steatotic liver disease (MASLD).”
Just Standing More Probably Won’t Help Your Heart
“Key Takeaways – Folks who worry they sit too much at work may consider getting a standing desk. New research shows that simply standing instead of sitting won’t bring a heart health benefit, and may even hurt. Getting active is the real healthy alternative to sitting, the researchers said.”
Medtronic MiniMed insulin pumps recalled over shorter-than-expected battery life
“Patients urged to carry extra batteries as Medtronic recall affects 24,595 insulin pumps that may stop delivering insulin sooner than expected.”
Can aerobic exercise help prevent brain fog caused by chemotherapy?
“Many women who receive chemotherapy experience a decreased ability to remember, concentrate, and/or think—commonly referred to as “chemo-brain” or “brain fog”—both short- and long-term. In a recent clinical trial of women initiating chemotherapy for breast cancer, those who simultaneously started an aerobic exercise program self-reported greater improvements in cognitive function and quality of life compared with those receiving standard care. The findings are published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society.”
Semaglutide boosts heart health, weight loss but may lead to gut problems
“Takeaways- Diabetes medications based on semaglutide deliver important cardiovascular benefits, according to a new meta-analysis. Untangling different health benefits resulting from semaglutide from those resulting from weight loss can be difficult. The authors used statistical tools to reach a clearer view of semaglutide’s cardiovascular benefits. The meta-analysis also investigated frequently reported gastrointestinal adverse effects accompanying the medication, as well as their connection to patients discontinuing treatment with semaglutide.”
